{{Rsnum
|rsid=621559
|Gene=WDR65
|Chromosome=1
|position=43179740
|Orientation=plus
|GMAF=0.2236
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=WDR65
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 12.4 | 87.6
| HCB | 5.8 | 38.0 | 56.2
| JPT | 9.7 | 45.1 | 45.1
| YRI | 15.6 | 47.6 | 36.7
| ASW | 12.3 | 35.1 | 52.6
| CHB | 5.8 | 38.0 | 56.2
| CHD | 9.2 | 43.1 | 47.7
| GIH | 8.9 | 40.6 | 50.5
| LWK | 12.7 | 46.4 | 40.9
| MEX | 6.9 | 32.8 | 60.3
| MKK | 3.8 | 42.3 | 53.8
| TSI | 0.0 | 5.9 | 94.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21460395
|Trait=None
|Title=A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer
|RiskAllele=
|Pval=0.000002
|OR=0.1600
|ORtxt=[NR] unit increase
|OA=1
}}

{{PMID Auto
|PMID=23180556
|Title=Leukocyte telomere length-related genetic variants in 1p34.2 and 14q21 loci contribute to the risk of esophageal squamous cell carcinoma
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}